Director, Liver Care Network Swedish
Gastroenterology
Dr. Kris V. Kowdley, MD
|
|
Give Review
Kris Kowdley is an expert in the field of Gastroenterology. He graduated from Icahn School of Medicine at Mount Sinai. Icahn School of Medicine at Mount Sinai is ranked 20 in research and 62 in primary care medicine He received 4 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification", "Elected Member" and "Fellow (FACG)". Kris Kowdley is a published doctor. He published 48 publications, including: 'The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma.' He is registered with Medicare and accepts Medicare payments.
Publications
- Editorial: improved understanding of the epidemiology of primary biliary Cirrhosis in South Korea.
- Hepatitis B Virus-Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.
- Disparate access to treatment regimens in chronic Hepatitis C patients: data from the TRIO network.
- Safety and Efficacy of Ledipasvir-Sofosbuvir in African Americans with Hepatitis C Virus Infection: A Retrospective Analysis of Phase 3 Data.
- Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.
- All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with Hepatitis C virus genotype 3 infection: ALLY-3 phase III study.
- ABT-450/ ritonavir and ABT-267 in combination with ABT-333 for the treatment of Hepatitis C virus.
- Improvement of health-related quality of life and work productivity in chronic Hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosb...
- GNPAT as a Hemochromatosis modifier gene: Another Iron in the Fire?
- A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel Disease.
- Relation between vitamin d status and nonalcoholic Fatty Liver disease in children.
- Efficacy of Obeticholic Acid in Patients with Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid.
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatoHepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.
- ABT-450/r-ombitasvir and dasabuvir with ribavirin for Hepatitis C with cirrhosis.
- Treatment of HCV with ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin.
- Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis.
- Serum hepcidin levels are associated with obesity but not Liver disease.
- Advances in the diagnosis and treatment of nonalcoholic steatoHepatitis.
- Phase 2b trial of interferon-free therapy for Hepatitis C virus genotype 1.
- Metal storage Disorders: Wilson disease and hemochromatosis.
- Iron Deficiency in Patients with Nonalcoholic Fatty Liver Disease is Associated with Obesity, Female Sex, and Low Serum Hepcidin.
- Serum ferritin is associated with non-alcoholic fatty Liver disease and decreased ÃŽÂ’-cell function in non-diabetic men and women.
- Reduced adiponectin signaling due to weight gain results in nonalcoholic steatoHepatitis through impaired mitochondrial biogenesis.
- Review of direct-acting antiviral agents for the treatment of chronic Hepatitis C.
- Allogeneic transplantation, fas signaling, and dysregulation of hepcidin.
- Effects of Ribavirin Dose Reduction vs Erythropoietin for Boceprevir-Related Anemia in Patients with Chronic HCV Genotype 1 Infection-a Randomized Trial.
- Diagnosis and treatment of hereditary Hemochromatosis: an update.
- A Phase 2a Trial of 12-Week Interferon-Free Therapy with Two Direct-Acting Antivirals (ABT-450/r, ABT-072) and Ribavirin in IL28B C/C Patients with Chronic Hepatitis C...
- Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 Hepatitis C infection: a rand...
- Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial.
- Iron Overload Causes Oxidative Stress and Impaired Insulin Signaling in AML-12 Hepatocytes.
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options.
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection.
- Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with Hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, mult...
- Exploratory study of oral combination antiviral therapy for Hepatitis C.
- Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty Liver disease.
- Prospective study of the progression of low-grade dysplasia in Ulcerative colitis using current cancer surveillance guidelines.
- Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatoHepatitis: a pioglitazone versus vitamin E versus placebo for the trea...
- Method for Microrna Isolation from Clinical Serum Samples.
- Metals and the Liver.
- Approach to a patient with elevated serum alkaline phosphatase.
- Transplantation of allogeneic T cells alters iron homeostasis in NOD/SCID mice.
- Dendritic cells in NASH: Friend or foe?
- Chemokines: potent mediators of hepatic inflammation and fibrosis in chronic Liver diseases.
- Management of chronic Hepatitis B infection.
- It TAK(es) 1 to prevent steatoHepatitis and tumorigenesis.
- The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma.
Schools
Mount Sinai School Of Medicine Of New York University
Oregon Health and Science University
Tufts Med School
Procedures Preformed
- Liver Biopsy
- Liver Test
Conditions Treated
- Autoimmune Hepatitis
- Cirrhosis
- Copper Metabolism Disorders
- Esophageal Ulcer
- View All
Doctors Specialties
- Gastroenterology
- Hepatology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Elected Member
- Fellow (FACG)
Education
-
Tufts Medical Center -
Oregon Health & Science University -
Icahn School of Medicine at Mount Sinai
Drug Facts
| NPI NUMBER | 1699850404 | |
| NPPES Provider LastName | KOWDLEY | |
| NPPES Provider FirstName | KRIS | |
| NPPES Provider ZIPCode | 981950001 | |
| NPPES Provider State | WA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 140.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699850404 |
| Last Name Of The Provider | KOWDLEY |
| First Name Of The Provider | KRIS |
| View All |
Similar Doctors
|
|
Dr. Carol S. Murakami, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Haritha Avula, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Renuka Bhattacharya, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michele C. Pulling, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erik M. Ness, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley Lee, MD |
|
|
Dr. Thomas D. Amankonah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard H. Driscoll Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James D. Lord, MD |
|
|
Rubeela Malik, MB
This Doctor is OpenDoctor Recommended.
|